Circadin Is Approved In The EU For Treatment Of Primary Insomnia In Patients Aged 55 Or Over For Up To 3 Months
TEL AVIV, Israel, July 5, 2010 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.Neurim.com) confirmed today that the European Commission (EC) has approved a change in treatment duration with…